# Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin

> **NCT06234046** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- Spontaneous Bacterial Peritonitis

## Interventions

- **DRUG:** Rifaximin 550Mg Tab
- **DRUG:** Ciprofloxacin 750 MG
- **DIAGNOSTIC_TEST:** ascitic fluid sample

## Key facts

- **NCT ID:** NCT06234046
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-28
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234046, "Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06234046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*